Stockscreener 앱 받기
35.87
4.54%
1.525
Dyne Therapeutics Inc 주식(DYN)의 최신 뉴스
Quarterly Metrics: Quick and Current Ratios for Dyne Therapeutics Inc (DYN) - The Dwinnex
Seven Eight Capital LP Grows Stock Position in Dyne Therapeutics, Inc. (NASDAQ:DYN) - MarketBeat
How To Trade (DYN) - Stock Traders Daily
Dyne Therapeutics director sells over $161k in company stock By Investing.com - Investing.com Canada
Dyne Therapeutics director sells over $161k in company stock - Investing.com India
Bronstein, Gewirtz & Grossman, LLC Is Investigating Dyne Therapeutics, Inc. (DYN) And Encourages Shareholders to Connect - AccessWire
Dyne Therapeutics Inc (DYN) Performance and Fundamentals Dashboard tells a completely different story - SETE News
Short Interest in Dyne Therapeutics, Inc. (NASDAQ:DYN) Decreases By 6.9% - MarketBeat
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc.DYN - PR Newswire
Dyne Therapeutics Inc’s latest rating changes from various analysts - Knox Daily
Dyne Therapeutics, Inc. (NASDAQ:DYN) Shares Acquired by Arizona State Retirement System - Defense World
Dyne Therapeutics Inc (DYN) presents a great opportunity, but the stock is slightly overvalued - US Post News
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Dyne Therapeutics, Inc. (DYN) And Encourages Shareholders to Reach Out - AccessWire
Rhumbline Advisers Acquires 23,266 Shares of Dyne Therapeutics, Inc. (NASDAQ:DYN) - MarketBeat
Rhumbline Advisers Raises Holdings in Dyne Therapeutics, Inc. (NASDAQ:DYN) - Defense World
DYN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Dyne Therapeutics, Inc. and Encourages Investors to Contact the Firm! - Business Wire
Dyne Therapeutics (NASDAQ:DYN) Rating Lowered to Sell at StockNews.com - MarketBeat
Dyne Therapeutics (NASDAQ:DYN) Rating Lowered to Sell at StockNews.com - Defense World
DYN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Dyne Therapeutics, Inc. and Encourages Investors to Contact the Firm! - PR Newswire
Dyne Therapeutics, Inc. (NASDAQ:DYN) Shares Bought by Federated Hermes Inc. - MarketBeat
Taking a look at what insiders are doing to gauge the Dyne Therapeutics Inc (DYN)’s direction - Knox Daily
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Dyne Therapeutics, Inc. (DYN) and Encourages Investors to Learn More About the Investigation - AccessWire
Trading Day Review: Dyne Therapeutics Inc (DYN) Gains Momentum, Closing at 33.07 - The Dwinnex
Dyne Therapeutics, Inc. (NASDAQ:DYN) Shares Purchased by TD Asset Management Inc - Defense World
TD Asset Management Inc Has $5.37 Million Stock Holdings in Dyne Therapeutics, Inc. (NASDAQ:DYN) - MarketBeat
Dyne Therapeutics, Inc.(DYN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - AccessWire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Dyne Therapeutics, Inc.(DYN) And Encourages Investors to Connect - AccessWire
Dyne Therapeutics (NASDAQ:DYN) Lowered to “Sell” at StockNews.com - Defense World
StockNews.com Lowers Dyne Therapeutics (NASDAQ:DYN) to Sell - MarketBeat
DYNE ALERT: Bragar Eagel & Squire, P.C. is Investigating Dyne Therapeutics, Inc. on Behalf - The Bakersfield Californian
DYNE ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
Check Out Dyne Therapeutics Inc (DYN)’s Trade Data Rather Than the Analysts’ Views - SETE News
Dyne Therapeutics, Inc. (NASDAQ:DYN) Shares Purchased by Bank of New York Mellon Corp - MarketBeat
Dyne Therapeutics, Inc. (NASDAQ:DYN) Shares Acquired by Bank of New York Mellon Corp - Defense World
Research Analysts’ Recent Ratings Changes for Dyne Therapeutics (DYN) - Defense World
Dyne therapeutics director sells over $55,000 in company stock - Investing.com
Dyne therapeutics director sells over $55,000 in company stock By Investing.com - Investing.com Canada
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Dyne Therapeutics, Inc. (DYN) - Business Wire
Dyne therapeutics director sells over $55,000 in company stock By Investing.com - Investing.com UK
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Dyne Therapeutics, Inc.(DYN) And Encourages Stockholders to Reach Out - AccessWire
Dyne Therapeutics Inc (DYN) stock analysis: A simple moving average approach - US Post News
Investors In Dyne Therapeutics, Inc. Are Invited To Join An Investigation For Possible Securities Related Infractions - StockTitan
Financial Health Report: Dyne Therapeutics Inc (DYN)’s Ratios Tell a Tale - The Dwinnex
Dyne Therapeutics (NASDAQ:DYN) Stock Price Down 4.4% - Defense World
Candriam S.C.A. Reduces Stake in Dyne Therapeutics, Inc. (NASDAQ:DYN) - Defense World
Candriam S.C.A. Cuts Holdings in Dyne Therapeutics, Inc. (NASDAQ:DYN) - MarketBeat
Dyne Therapeutics (NASDAQ:DYN) Stock Price Down 4.4% - MarketBeat
Dyne Therapeutics, Inc. (DYN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - AccessWire
Dyne Therapeutics CEO, President & Director Acquires 640% More Stock - Simply Wall St
John Cox Acquires 32,000 Shares of Dyne Therapeutics, Inc. (NASDAQ:DYN) Stock - Defense World
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Dyne Therapeutics, Inc.(DYN) and Encourages Stockholders to Learn More About the Investigation - AccessWire
(DYN) INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC - GlobeNewswire
The Escalator: MM+M, Dyne Therapeutics, EyePoint Pharmaceuticals and more - MM+M Online
Petri Dish: Dyne’s Duchenne data; Foghorn hires BMS leader - The Business Journals
Dyne Therapeutics (NASDAQ:DYN) Given “Buy” Rating at HC Wainwright - Defense World
Dyne therapeutics CEO buys over $1m in company stock - Investing.com India
Dyne therapeutics director sells over $1.4m in company stock - Investing.com
Dyne Therapeutics, Inc. (NASDAQ:DYN) CEO Buys $1,057,280.00 in Stock - MarketBeat
Dyne therapeutics director sells over $1.4m in company stock By Investing.com - Investing.com Canada
Dyne therapeutics CEO buys over $1m in company stock By Investing.com - Investing.com Australia
Dyne therapeutics CEO buys over $1m in company stock By Investing.com - Investing.com Canada
Dyne therapeutics CEO buys over $1m in company stock - Investing.com
Dyne therapeutics CEO buys over $1m in company stock By Investing.com - Investing.com UK
Dyne Therapeutics: Management Merry-Go-Round, Shaky Data Rock Wall Street (DYN) - Seeking Alpha
DYN Investors Have Opportunity to Join Dyne Therapeutics, Inc. Fraud Investigation with the Schall Law Firm - Business Wire
Dyne therapeutics director sells over $1.4m in company stock By Investing.com - Investing.com UK
Dyne Therapeutics (NASDAQ:DYN) Shares Up 7.9% - MarketBeat
Dyne Reports Mixed Data From DMD Study, Key Executives Step Down - Nasdaq
Bronstein, Gewirtz & Grossman, LLC Encourages Dyne Therapeutics, Inc.(DYN) Investors to Inquire about Securities Investigation - AccessWire
HC Wainwright Reiterates "Buy" Rating for Dyne Therapeutics (NASDAQ:DYN) - MarketBeat
Biotech Crashes, Executives Depart Despite 'Unprecedented' Results - Investor's Business Daily
Dyne stock tumbles 31% amid drug updates, management changes - MSN
Dyne Therapeutics’ (DYN) “Outperform” Rating Reaffirmed at Oppenheimer - Defense World
1.07%
2.16%
자본화:
|
볼륨(24시간):